Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d,in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft.

NCT00174759 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00174759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d,in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft.
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
Not reported
Enrollment
1,460 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases